{
  "ticker": "AVBP",
  "success": true,
  "price": {
    "current": 22.5,
    "currency": "USD",
    "day_high": 24.27,
    "day_low": 22.24,
    "52_week_high": 29.71,
    "52_week_low": 15.47
  },
  "market_cap": {
    "value": 928830592.0,
    "currency": "USD"
  },
  "shares_outstanding": 41281361.0,
  "volume": {
    "last": 199697,
    "average_30d": 435704
  },
  "valuation": {
    "pe_ratio": null,
    "forward_pe": -5.751681,
    "price_to_book": 3.0136619
  },
  "company_info": {
    "name": "ArriVent BioPharma, Inc.",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "balance_sheet": {
    "success": true,
    "period_date": "2025-09-30",
    "total_assets": 326555000.0,
    "total_liabilities": 21558000.0,
    "stockholders_equity": 304997000.0,
    "cash": 112672000.0,
    "marketable_securities": 187594000.0,
    "total_liquidity": 300266000.0,
    "total_debt": 56000.0,
    "long_term_debt": 0.0,
    "current_debt": 56000.0,
    "error": null
  },
  "data_quality": {
    "flags": [],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": true,
    "has_balance_sheet": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-29T16:30:09.214591",
    "url": "https://finance.yahoo.com/quote/AVBP",
    "data_hash": "2b154df6838f485e"
  }
}